A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model

Critical Reviews in Toxicology

Volumn 42, Issue 2, 2012, Pages 147-168

  Haighton, Lois A ^a   Lynch, Barry S ^a   Magnuson, Bernadene A ^a   Nestmann, Earle R ^a  

^a Cantox Health Sciences International   (Canada)

Author keywords

Genotoxicity; Margin of exposure; Maximum limits; Mechanisms; Nephropathy; Ochratoxin A (OTA); Renal tumors; Risk assessment; Threshold

Indexed keywords

ARISTOLOCHIC ACID; OCHRATOXIN; OCHRATOXIN ALPHA; UNCLASSIFIED DRUG;

AMES TEST; ARISTOLOCHIC ACID NEPHROPATHY; BALKAN ENDEMIC NEPHROPATHY; CANADA; CARCINOGEN DNA INTERACTION; CHEMICAL CARCINOGENESIS; CYTOGENETICS; DIETARY INTAKE; DNA DAMAGE; DOSE RESPONSE; ENDEMIC DISEASE; EPIGENETICS; EUROPEAN UNION; FOOD CONTAMINATION; FOOD SAFETY; GENOTOXICITY; HAZARD ASSESSMENT; HEALTH HAZARD; HUMAN; KIDNEY CANCER; LIFESPAN; NEPHROTOXICITY; NONHUMAN; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; PRACTICE GUIDELINE; REFERENCE VALUE; REVIEW; RISK ASSESSMENT; SINGLE STRANDED DNA BREAK; SISTER CHROMATID EXCHANGE; TOXICOKINETICS; DNA ADDUCT; TOXICOLOGY;

ANIMALS; CANADA; CARCINOGENS; DIET; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; FOOD ANALYSIS; FOOD CONTAMINATION; HUMANS; KIDNEY; OCHRATOXINS; OXIDATIVE STRESS; RISK ASSESSMENT; RISK FACTORS;

ANIMALIA; RATTUS;

EID: 84856204525     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2011.636342     Document Type: Review

References (115)

1. Adler M, Müller K, Rached E, Dekant W, Mally A. (2009). Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 30:711-719.
2. Ali R, Mittelstaedt RA, Shaddock JG, Bhalli JA, Heflich RH. (2010). Micronucleus induction by ochratoxin A in CH9 and TK6 cells. Environ Mol Mutagen 51:728 [abstract P78].
3. Arbillaga L, Azqueta A, van Delft JH, López de Cerain A. (2007). In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. Toxicol Appl Pharmacol 220:216-224. (Pubitemid 46507575)
4. Arlt VM, Stiborová M, vom Brocke J, Simões ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH. (2007). Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 28:2253-2261. (Pubitemid 350111583)
5. Auffray Y, Boutibonnes P. (1986). Evaluation of the genotoxic activity of some mycotoxins using Escherichia coli in the SOS spot test. Mutat Res 171:79-82. (Pubitemid 16051626)
6. Bansal J, Pantazopoulos P, Tam J, Cavlovic P, Kwong K, Turcotte AM, Lau BP, Scott PM. (2011). Surveys of rice sold in Canada for aflatoxins, ochratoxin A and fumonisins. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 28:767-774.
7. Bartsch H, Malaveille C, Camus AM, Martel-Planche G, Brun G, Hautefeuille A, Sabadie N, Barbin A, Kuroki T, Drevon C, Piccoli C, Montesano R. (1980). Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems. Mutat Res 76:1-50. (Pubitemid 10066844)
8. Bendele AM, Neal SB, Oberly TJ, Thompson CZ, Bewsey BJ, Hill LE, Rexroat MA, Carlton WW, Probst GS. (1985). Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assays. Food Chem Toxicol 23:911-918. (Pubitemid 16201481)
9. Bose S, Sinha SP. (1994). Modulation of ochratoxin-produced genotoxicity in mice by vitamin C. Food Chem Toxicol 32:533-537. (Pubitemid 24234384)
10. Brambilla G, Martelli A. (2004). Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens. Toxicology 196:1-19. (Pubitemid 38228348)
11. Brusick D. (1986). Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ Mutagen 8:879-886. (Pubitemid 17188042)
12. Castegnaro M, Mohr U, Pfohl-Leszkowicz A, Estève J, Steinmann J, Tillmann T, Michelon J, Bartsch H. (1998). Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int J Cancer 77:70-75. (Pubitemid 28308554)
13. Castegnaro M, Canadas D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A. (2006). Balkan endemic nephropathy: role of ochratoxins A through biomarkers. Mol Nutr Food Res 50:519-529. (Pubitemid 43944161)
14. Cavin C, Delatour T, Marin-Kuan M, Holzhäuser D, Higgins L, Bezençon C, Guignard G, Junod S, Richoz-Payot J, Gremaud E, Hayes JD, Nestler S, Mantle P, Schilter B. (2007). Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol Sci 96:30-39. (Pubitemid 46323206)
15. Commission of the European Communities. (2006). Commission Regulation (EC) No 1881/2006 19 December 2006 setting maximum levels for certain contaminants in foodstuffs (Text with EEA relevance) [L364]. Off J Eur Union 49:5-24. Available at: http://eur-lex.europa.eu/LexUriServ/site/en/oj/2006/l- 364/l-36420061220en00050024.pdf. Accessed on June 10, 2011.
16. Cooray R. (1984). Effects of some mycotoxins on mitogen-induced blastogenesis and SCE frequency in human lymphocytes. Food Chem Toxicol 22:529-534. (Pubitemid 14096839)
17. Coronel MB, Sanchis V, Ramos AJ, Marin S. (2010). Review. Ochratoxin A: presence in human plasma and intake estimation. Food Sci Technol Int 16:5-18.
18. Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, van Ypersele de Strihou C. (1994). Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 45: 1680-1688. (Pubitemid 24207504)
19. Creppy EE, Kane A, Dirheimer G, Lafarge-Frayssinet C, Mousset S, Frayssinet C. (1985). Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol Lett 28:29-35. (Pubitemid 16249999)
20. Czakai K, Müller K, Mosesso P, Pepe G, Schulze M, Gohla A, Patnaik D, Dekant W, Higgins JM, Mally A. (2011). Perturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin a toxicity and carcinogenicity? Toxicol Sci 122:317-329.
21. Degen GH, Gerber MM, Obrecht-Pflumio S, Dirheimer G. (1997). Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures. Arch Toxicol 71:365-371. (Pubitemid 27214469)
22. Delatour T, Mally A, Richoz J, Ozden S, Dekant W, Ihmels H, Otto D, Gasparutto D, Marin-Kuan M, Schilter B, Cavin C. (2008). Absence of 2 -deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol Nutr Food Res 52:472-482.
23. Dietrich DR, Heussner AH, O'Brien E. (2005). Ochratoxin A: comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans). Food Addit Contam 22 Suppl 1:45-52. (Pubitemid 44574573)
24. Dopp E, Müller J, Hahnel C, Schiffmann D. (1999). Induction of genotoxic effects and modulation of the intracellular calcium level in syrian hamster embryo (SHE) fibroblasts caused by ochratoxin A. Food Chem Toxicol 37:713-721. (Pubitemid 29397359)
25. Duarte SC, Pena A, Lino CM. (2011). Human ochratoxin a biomarkers-from exposure to effect. Crit Rev Toxicol 41:187-212.
26. EFSA (2006). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to ochratoxin A in food (Question number: EFSA-Q-2005-154, adopted on 4 April 2006 by European Food Safety Authority). EFSA J 365:1-56. Available at: http://www.efsa.europa.eu/en/scdocs/ scdoc/365.htm. Accessed on June 10, 2011.
27. Ehrlich V, Darroudi F, Uhl M, Steinkellner H, Gann M, Majer BJ, Eisenbauer M, Knasmüller S. (2002). Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem Toxicol 40:1085-1090. (Pubitemid 34626871)
28. El Adlouni C, Pinelli E, Azémar B, Zaoui D, Beaune P, Pfohl-Leszkowicz A. (2000). Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: role of CYP 2C9 and microsomal glutathione-S- transferase. Environ Mol Mutagen 35:123-131. (Pubitemid 30171821)
29. Faucet V, Pfohl-Leszkowicz A, Dai J, Castegnaro M, Manderville RA. (2004). Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem Res Toxicol 17:1289-1296. (Pubitemid 39265886)
30. Föllmann W, Lucas S. (2003). Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system. Arch Toxicol 77:298-304. (Pubitemid 36714077)
31. Föllmann W, Hillebrand IE, Creppy EE, Bolt HM. (1995). Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha. Arch Toxicol 69:280-286.
32. Galloway SM, Marshall RR, Ishidate M Jr, Brusick D, Ashby J, Myhr BC. (1991). Genotoxicity under extreme culture conditions. a report from ICPEMC Task Group 9 (International Commission for Protection Against Environmental Mutagens and Carcinogens). Mutat Res 257:147-204.
33. Gautier J, Richoz J, Welti DH, Markovic J, Gremaud E, Guengerich FP, Turesky RJ. (2001). Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes. Chem Res Toxicol 14:34-45. (Pubitemid 32064373)
34. Gluhovschi G, Margineanu F, Velciov S, Gluhovschi C, Bob F, Petrica L, Bozdog G, Trandafirescu V, Modalca M. (2011). Fifty years of Balkan endemic nephropathy in Romania: some aspects of the endemic focus in the Mehedinti county. Clin Nephrol 75:34-48.
35. Green MH, Muriel WJ. (1976). Mutagen testing using TRP+ reversion in Escherichia coli. Mutat Res 38:3-32.
36. Grollman AP, Jelakovic B. (2007). Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. J Am Soc Nephrol 18:2817-2823. (Pubitemid 350064082)
37. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelic M, Jelakovic B. (2007). Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 104:12129-12134. (Pubitemid 47185641)
38. Gross-Steinmeyer K, Weymann J, Hege HG, Metzler M. (2002). Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin a in cultured rat and human primary hepatocytes. J Agric Food Chem 50:938-945. (Pubitemid 34163649)
39. Grosse Y, Baudrimont I, Castegnaro M, Betbeder AM, Creppy EE, Dirheimer G, Pfohl-Leszkowicz A. (1995). Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells. Chem Biol Interact 95:175-187.
40. Hagelberg S, Hult K, Fuchs R. (1989). Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J Appl Toxicol 9:91-96. (Pubitemid 19108620)
41. Halmes NC, Roberts SM, Tolson JK, Portier CJ. (2000). Reevaluating cancer risk estimates for short-term exposure scenarios. Toxicol Sci 58:32-42.
42. Health Canada. (2006). Guidelines for Canadian Drinking Water Quality: Guideline Technical Document-Arsenic. Ottawa, ON: Health Canada, Water Quality and Health Bureau, Healthy Environments and Consumer Safety Branch. Available at: http://www.hc-sc.gc.ca/ewh-semt/pubs/water-eau/arsenic/index-eng.php http://www.hc-sc.gc.ca/ewh-semt/alt-formats/hecs-sesc/pdf/pubs/water-eau/ arsenic/arsenic-eng.pdf. Accessed on June 10, 2011.
43. Health Canada. (2009). Information Document on Health Canada's Proposed Maximum Limits (Standards) for the Presence of Mycotoxin Ochratoxin A in Foods: Revised- February 2009. Ottawa, ON: Health Canada, Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch. Available at: http://www.hc-sc.gc.ca/fn-an/consult/limits-max-seuils/myco-consult-ochra-eng. php. Accessed on June 10, 2011.
44. Hibi D, Suzuki Y, Ishii Y, Jin M, Watanabe M, Sugita-Konishi Y, Yanai T, Nohmi T, Nishikawa A, Umemura T. (2011). Site-specific in vivo mutagenicity in the kidney of gpt delta rats given a carcinogenic dose of ochratoxin A. Toxicol Sci 122:406-414.
45. IARC (International Agency for Research on Cancer). (1993). Ochratoxin A. In: Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Working Group on the Evaluation of Carcinogen Risks to Humans Meeting, June 9-16, 1992, Lyon, France, 1992. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 56. Lyon, France: World Health Organization (WHO), International Agency for Research on Cancer, 489-521. Available at: http://monographs.iarc.fr/ENG/ Monographs/vol56/index. php. Accessed on June 10, 2011.
46. JECFA (Joint FAO/WHO Expert Committee on Food Additives). (2008). Ochratoxin A (addendum). In: Safety Evaluation of Certain Food Additives and Contaminants. Prepared by the Sixty-eighth meeting of the Joint FAO/WHO Expert Committee on Food Additives, June 19-28, 2007, Geneva, Switz. WHO Food Additive Series, vol 59. Geneva, Switz.: Food and Agriculture Organization of the United Nations (FAO), World Health Organization (WHO), 357-429, 454. Available at: http://whqlibdoc.who.int/publications/2008/9789241660594-eng.pdf. Accessed on June 10, 2011.
47. Jennings-Gee JE, Tozlovanu M, Manderville R, Miller MS, Pfohl-Leszkowicz A, Schwartz GG. (2010). Ochratoxin A: In Utero Exposure in Mice Induces Adducts in Testicular DNA. Toxins (Basel) 2:1428-1444.
48. Kamp HG, Eisenbrand G, Janzowski C, Kiossev J, Latendresse JR, Schlatter J, Turesky RJ. (2005). Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol Nutr Food Res 49:1160-1167. (Pubitemid 43004349)
49. Kanki K, Nishikawa A, Masumura K, Umemura T, Imazawa T, Kitamura Y, Nohmi T, Hirose M. (2005). In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N-nitrosopyrrolidine, 2-amino-3-methylimidazo [4,5-f]quinoline, and di(2-ethylhexyl)phthalate. Mol Carcinog 42:9-17. (Pubitemid 40041481)
50. Kirkland D, Aardema M, Henderson L, Müller L. (2005). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 584:1-256. (Pubitemid 40922793)
51. Klaric MS, Darabos D, Rozgaj R, Kasuba V, Pepeljnjak S. (2010). Beauvericin and ochratoxin A genotoxicity evaluated using the alkaline comet assay: single and combined genotoxic action. Arch Toxicol 84:641-650.
52. Krivobok S, Olivier P, Marzin DR, Seigle-Murandi F, Steiman R. (1987). Study of the genotoxic potential of 17 mycotoxins with the SOS Chromotest. Mutagenesis 2:433-439. (Pubitemid 17162174)
53. Krogh P, Axelsen NH, Elling F, Gyrd-Hansen N, Hald B, Hyldgaard-Jensen J, Larsen AE, Madsen A, Mortensen HP, Moller T, Petersen OK, Ravnskov U, Rostgaard M, Aalund O. (1974). Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feed. Acta Pathol Microbiol Scand Suppl 0:1-21.
54. Krogh P, Elling F, Friis C, Hald B, Larsen AE, Lillehøj EB, Madsen A, Mortensen HP, Rasmussen F, Ravnskov U. (1979). Porcine nephropathy induced by long-term ingestion of ochratoxin A. Vet Pathol 16:466-475. (Pubitemid 9219861)
55. Kuiper-Goodman T. (2004). Risk assessment and risk management of mycotoxins in food. In: Magan N, Olsen M, eds. Mycotoxins in Food: Detection and Control. Boca Raton, FL: CRC Press, 3-31.
56. Kuiper-Goodman T, Scott PM. (1989). Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci 2:179-248.
57. Kuiper-Goodman T, Hilts C, Billiard SM, Kiparissis Y, Richard ID, Hayward S. (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27:212-240.
58. Kumari D, Sinha SP. (1994). Effect of retinol on ochratoxin-produced genotoxicity in mice. Food Chem Toxicol 32:471-475. (Pubitemid 24205014)
59. Lebrun S, Golka K, Schulze H, Föllmann W. (2006). Glutathione S-transferase polymorphisms and ochratoxin A toxicity in primary human urothelial cells. Toxicology 224:81-90.
60. Li J, Yin S, Dong Y, Fan L, Hu H. (2011). p53 activation inhibits ochratoxin A-induced apoptosis in monkey and human kidney epithelial cells via suppression of JNK activation. Biochem Biophys Res Commun 411:458-463.
61. Malaveile C, Brun G, Bartsch H. (1991). Genotoxicity of ochratoxin A and structurally related compounds in Escheriehia coli strains: studies on their mode of action. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, eds. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. IARC Scientific Publications no 115. Lyon, France: World Health Organization (WHO), International Agency for Research on Cancer (IARC), 261-266.
62. Mally A, Dekant W. (2009). Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol Nutr Food Res 53:467-478.
63. Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H, Völkel W, Dekant W. (2004). Ochratoxin A: lack of formation of covalent DNA adducts. Chem Res Toxicol 17:234-242. (Pubitemid 38252503)
64. Mally A, Pepe G, Ravoori S, Fiore M, Gupta RC, Dekant W, Mosesso P. (2005a). Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem Res Toxicol 18:1253-1261. (Pubitemid 41170249)
65. Mally A, Völkel W, Amberg A, Kurz M, Wanek P, Eder E, Hard G, Dekant W. (2005b). Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats. Chem Res Toxicol 18:1242-1252. (Pubitemid 41170248)
66. Mally A, Hard GC, Dekant W. (2007). Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats. Food Chem Toxicol 45:2254-2260. (Pubitemid 47451578)
67. Manderville RA. (2005). A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction. Chem Res Toxicol 18:1091-1097. (Pubitemid 41022841)
68. Manolova Y, Manolov G, Parvanova L, Petkova-Bocharova T, Castegnaro M, Chernozemsky IN. (1990). Induction of characteristic chromosomal aberrations, particularly X-trisomy, in cultured human lymphocytes treated by ochratoxin A, a mycotoxin implicated in Balkan endemic nephropathy. Mutat Res 231:143-149. (Pubitemid 20252547)
69. Mantle PG. (2009). Minimum tolerable exposure period and maximum threshold dietary intake of ochratoxin A for causing renal cancer in male Dark Agouti rats. Food Chem Toxicol 47:2419-2424.
70. Mantle P, Kulinskaya E. (2010). Lifetime, low-dose ochratoxin A dietary study on renal carcinogenesis in male Fischer rats. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27:1566-1573.
71. Mantle PG, Nagy JM. (2008). Binding of ochratoxin A to a urinary globulin: a new concept to account for gender difference in rat nephrocarcinogenic responses. Int J Mol Sci 9:719-735. (Pubitemid 351776192)
72. Mantle P, Kulinskaya E, Nestler S. (2005). Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit Contam 22 Suppl 1:58-64. (Pubitemid 44574575)
73. Mantle PG, Faucet-Marquis V, Manderville RA, Squillaci B, Pfohl-Leszkowicz A. (2010). Structures of covalent adducts between DNA and ochratoxin a: a new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 23:89-98.
74. Marin-Kuan M, Nestler S, Verguet C, Bezençon C, Piguet D, Mansourian R, Holzwarth J, Grigorov M, Delatour T, Mantle P, Cavin C, Schilter B. (2006). A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat. Toxicol Sci 89:120-134. (Pubitemid 43013761)
75. Marin-Kuan M, Cavin C, Delatour T, Schilter B. (2008). Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms. Toxicon 52:195-202.
76. Miljkovic A, Pfohl-Leszkowicz A, Dobrota M, Mantle PG. (2003). Comparative responses to mode of oral administration and dose of ochratoxin A or nephrotoxic extract of Penicillium polonicum in rats. Exp Toxicol Pathol 54:305-312. (Pubitemid 36362236)
77. Mori H, Kawai K, Ohbayashi F, Kuniyasu T, Yamazaki M, Hamasaki T, Williams GM. (1984). Genotoxicity of a variety of mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes. Cancer Res 44:2918-2923. (Pubitemid 14083209)
78. Mosesso P, Cinelli S, Piñero J, Bellacima R, Pepe G. (2008). In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity. Chem Res Toxicol 21:1235-1243. (Pubitemid 351967388)
79. Murdoch DJ, Krewski D, Wargo J. (1992). Cancer risk assessment with intermittent exposure. Risk Anal 12:569-577. (Pubitemid 23050544)
80. Nedelko T, Arlt VM, Phillips DH, Hollstein M. (2009). TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours. Int J Cancer 124:987-990.
81. Nestmann ER, Bryant DW, Carr CJ. (1996). Toxicological significance of DNA adducts: summary of discussions with an expert panel. Regul Toxicol Pharmacol 24:9-18.
82. NTP (National Toxicology Program). (1989). Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N rats (Gavage Studies). Technical Report Series no 358. Department of Health and Human Services. Research Triangle Park, NC: National Toxicology Program. Available at: http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/tr358.pdf. Accessed on June 10, 2011.
83. NTP (National Toxicology Program). (2011) Aristolochic acids. Rep Carcinog 12:45-49.
84. O'Brien E, Heussner AH, Dietrich DR. (2001). Species-, sex-, and cell type-specific effects of ochratoxin A and B. Toxicol Sci 63:256-264. (Pubitemid 32982799)
85. Palma N, Cinelli S, Sapora O, Wilson SH, Dogliotti E. (2007). Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. Chem Res Toxicol 20:1031-1037. (Pubitemid 47204816)
86. Pfohl-Leszkowicz A. (2009). Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 60:465-483.
87. Pfohl-Leszkowicz A, Castegnaro M. (2005). Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation. Food Addit Contam 22 Suppl 1:75-87. (Pubitemid 44574577)
88. Pfohl-Leszkowicz A, Chakor K, Creppy E, Dirheimer G. (1991). DNA adduct formation in mice treated with ochratoxin A. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, eds. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. (IARC Scientific Publications no 115. Lyon, France: World Health Organization (WHO), International Agency for Research on Cancer (IARC), 245-253.
89. Pfohl-Leszkowicz A, Grosse Y, Castegnaro M, Nicolov IG, Chernozemsky IN, Bartsch H, Betbeder AM, Creppy EE, Dirheimer G (1993). Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. In: Phillips DH, Castegnaro M, Bartsch H, eds. Postlabelling Methods for the Detection of DNA Adducts. IARC Scientific Publications no 124. Lyon, France: World Health Organization (WHO), International Agency for Research on Cancer (IARC), 141-148.
90. Rached E, Pfeiffer E, Dekant W, Mally A. (2006). Ochratoxin A: apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics? Toxicol Sci 92:78-86. (Pubitemid 43985792)
91. Ringot D, Chango A. (2010). Risk assessment of ochratoxin A (OTA). In: Rai M, Varma A, eds. Mycotoxins in Food, Feed and Bioweapons. Heidelberg, Germany: Springer-Verlag, 307-328.
92. Schilter B, Marin-Kuan M, Delatour T, Nestler S, Mantle P, Cavin C. (2005). Ochratoxin A: potential epigenetic mechanisms of toxicity and carcinogenicity. Food Addit Contam 22 Suppl 1:88-93. (Pubitemid 44574578)
93. Schlatter C, Studer-Rohr J, Rásonyi T. (1996). Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam 13 Suppl:43-44. (Pubitemid 27011139)
94. Simarro Doorten Y, Nijmeijer S, de Nijs-Tjon L, Fink-Gremmels J. (2006). Metabolism-mediated Ochratoxin A genotoxicity in the single-cell gel electrophoresis (Comet) assay. Food Chem Toxicol 44:261-270. (Pubitemid 41781984)
95. Slade N, Moll UM, Brdar B, Zoric A, Jelakovic B. (2009). p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy. Mutat Res 663:1-6.
96. Stachurska A, Kozakowska M, Jozkowicz A, Dulak J, Loboda A. (2011). Aristolochic acid I and ochratoxin A differentially regulate VEGF expression in porcine kidney epithelial cells-the involvement of SP-1 and HIFs transcription factors. Toxicol Lett 204:118-126.
97. Stefanovic V, Polenakovic M. (2009). Fifty years of research in Balkan endemic nephropathy: where are we now? Nephron Clin Pract 112:c51-c56.
98. Stefanovic V, Polenakovic M, Toncheva D. (2011). Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease. Pathol Biol 59:286-291.
99. Stetina R, Votava M. (1986). Induction of DNA single-strand breaks and DNA synthesis inhibition by patulin, ochratoxin A, citrinin, and aflatoxin B1 in cell lines CHO and AWRF. Folia Biol (Praha) 32:128-144.
100. Tam J, Pantazopoulos P, Scott PM, Moisey J, Dabeka RW, Richard ID. (2011). Application of isotope dilution mass spectrometry: determination of ochratoxin A in the Canadian Total Diet Study. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 28:754-761.
101. Turesky RJ. (2005). Perspective: ochratoxin A is not a genotoxic carcinogen. Chem Res Toxicol 18:1082-1090. (Pubitemid 41022840)
102. USDA (US Department of Agriculture) (2000). 1994-1996, 1998 Continuing Survey of Food Intakes by Individuals (CSFII) and Diet and Health Knowledge Survey (DHKS) [PB2000-500027]. Riverdale (MD).
103. US EPA (US Environmental Protection Agency). (2005a). Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001B. Washington, DC: US Environmental Protection Agency, Risk Assessment Forum, National Center for Environmental Assessment (NCEA). Available at: http://www.epa.gov/raf/publications/pdfs/ CANCER-GUIDELINES-FINAL-3-25-05.PDF. Accessed on June 10, 2011.
104. US EPA (US Environmental Protection Agency). (2005b). Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. EPA/630/R-03/003F. Washington, DC: US Environmental Protection Agency, Risk Assessment Forum. Available at: http://www.epa.gov/ttn/atw/childrens-supplement- final.pdf. Accessed on June 10, 2011.
105. Vettorazzi A, de Trocóniz IF, González-Peñas E, Arbillaga L, Corcuera LA, Gil AG, de Cerain AL. (2011). Kidney and liver distribution of ochratoxin A in male and female F344 rats. Food Chem Toxicol 49:1935-1942.
106. Waddell WJ. (2006). Critique of dose response in carcinogenesis. Hum Exp Toxicol 25:413-436. (Pubitemid 44139568)
107. Wehner FC, Thiel PG, van Rensburg SJ, Demasius IP. (1978). Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins. Mutat Res 58:193-203. (Pubitemid 9054916)
108. Wu F. (2004). Mycotoxin risk assessment for the purpose of setting international regulatory standards. Environ Sci Technol 38:4049-4055. (Pubitemid 39014185)
109. Wu Q, Dohnal V, Huang L, Kuca K, Wang X, Chen G, Yuan Z. (2011). Metabolic pathways of ochratoxin A. Curr Drug Metab 12:1-10.
110. Würgler FE, Friederich U, Schlatter J. (1991). Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102. Mutat Res 261:209-216.
111. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K. (1988). Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ Mol Mutagen 11 Suppl 12:1-157.
112. Zeljezic D, Domijan AM, Peraica M. (2006). DNA damage by ochratoxin A in rat kidney assessed by the alkaline comet assay. Braz J Med Biol Res 39:1563-1568. (Pubitemid 46357841)
113. Zepnik H, Pähler A, Schauer U, Dekant W. (2001). Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? Toxicol Sci 59, 59-67. (Pubitemid 32117981)
114. Zepnik H, Völkel W, Dekant W. (2003). Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol Appl Pharmacol 192:36-44. (Pubitemid 37205116)
115. Zhang X, Boesch-Saadatmandi C, Lou Y, Wolffram S, Huebbe P, Rimbach G. (2009). Ochratoxin A induces apoptosis in neuronal cells. Genes Nutr 4:41-48.